Correlation Between BioInvent International and Swedish Orphan
Can any of the company-specific risk be diversified away by investing in both BioInvent International and Swedish Orphan at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioInvent International and Swedish Orphan into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioInvent International AB and Swedish Orphan Biovitrum, you can compare the effects of market volatilities on BioInvent International and Swedish Orphan and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioInvent International with a short position of Swedish Orphan. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioInvent International and Swedish Orphan.
Diversification Opportunities for BioInvent International and Swedish Orphan
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between BioInvent and Swedish is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding BioInvent International AB and Swedish Orphan Biovitrum in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Swedish Orphan Biovitrum and BioInvent International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioInvent International AB are associated (or correlated) with Swedish Orphan. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Swedish Orphan Biovitrum has no effect on the direction of BioInvent International i.e., BioInvent International and Swedish Orphan go up and down completely randomly.
Pair Corralation between BioInvent International and Swedish Orphan
Assuming the 90 days trading horizon BioInvent International AB is expected to generate 1.13 times more return on investment than Swedish Orphan. However, BioInvent International is 1.13 times more volatile than Swedish Orphan Biovitrum. It trades about 0.0 of its potential returns per unit of risk. Swedish Orphan Biovitrum is currently generating about -0.14 per unit of risk. If you would invest 4,330 in BioInvent International AB on September 1, 2024 and sell it today you would lose (30.00) from holding BioInvent International AB or give up 0.69% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 95.65% |
| Values | Daily Returns |
BioInvent International AB vs. Swedish Orphan Biovitrum
Performance |
| Timeline |
| BioInvent International |
| Swedish Orphan Biovitrum |
BioInvent International and Swedish Orphan Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BioInvent International and Swedish Orphan
The main advantage of trading using opposite BioInvent International and Swedish Orphan positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioInvent International position performs unexpectedly, Swedish Orphan can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Swedish Orphan will offset losses from the drop in Swedish Orphan's long position.| BioInvent International vs. Hansa Biopharma AB | BioInvent International vs. Saniona AB | BioInvent International vs. Active Biotech AB | BioInvent International vs. Oncopeptides AB |
| Swedish Orphan vs. Kancera AB | Swedish Orphan vs. Cyxone AB | Swedish Orphan vs. Lidds AB | Swedish Orphan vs. Cantargia AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |